rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1981-4-13
|
pubmed:abstractText |
Fifty-one patients suffering from non-microcellular bronchial cancer with metastasis were divided at random into two groups: 33 patients received BACFON polychemotherapy, 18 patients did not receive chemotherapy. There was no global significant difference between the two groups (total mean survival time : 22 weeks with good therapy and 18 without), but a significant difference could be observed if there was an early response (M.S.T. : 38 weeks) compared to no response (M.S.T. : 15 weeks). Similar results were obtained when radiotherapy was associated (M.S.T. : 34 weeks) compared to chemotherapy without radiotherapy (M.S.T. : 22 weeks).
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0301-0279
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
742-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:95488-Adenocarcinoma,
pubmed-meshheading:95488-Adult,
pubmed-meshheading:95488-Aged,
pubmed-meshheading:95488-Bleomycin,
pubmed-meshheading:95488-Bronchial Neoplasms,
pubmed-meshheading:95488-Carcinoma, Small Cell,
pubmed-meshheading:95488-Carcinoma, Squamous Cell,
pubmed-meshheading:95488-Cyclophosphamide,
pubmed-meshheading:95488-Doxorubicin,
pubmed-meshheading:95488-Drug Therapy, Combination,
pubmed-meshheading:95488-Fluorouracil,
pubmed-meshheading:95488-Humans,
pubmed-meshheading:95488-Mechlorethamine,
pubmed-meshheading:95488-Middle Aged,
pubmed-meshheading:95488-Neoplasm Metastasis,
pubmed-meshheading:95488-Vincristine
|
pubmed:year |
1979
|
pubmed:articleTitle |
[Chemotherapy of non-microcellular disseminated bronchial cancer (author's transl)].
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial
|